SpaceX Stock Optimism Hinges on Unverified UBS Estimates

SpaceX stock attracted investor attention on Sept. 29–30, 2026, after secondary reports attributed bullish Q3 revenue and adjusted-EBITDA estimates to UBS. Traders also registered a two-week high in short-volume, though no UBS research note or SpaceX filing verifying the figures was found.

UBS Estimates and Business Mix

Secondary reports attributed to UBS a reiterated Buy rating and a $210 price target, projecting Q3 2026 revenue of $13.8 billion and adjusted EBITDA of $7.5 billion, about 7% and 9% above cited consensus estimates. The reports broke down the quarter by business line, assigning $7.6 billion to AI-related sales, $4.9 billion to connectivity revenue—a reported 59.0% year-over-year increase—and $1.3 billion to space revenue. The AI figure was linked to scaling an Anthropic agreement and an initial contribution from Google. If accurate, this would make AI the largest segment and shift SpaceX’s revenue profile toward compute-related services.

The reports also attributed Q3 capital expenditures of $19.3 billion and a quarterly cash burn of $13.2 billion to AI-compute infrastructure, Starlink, and launch operations. They assumed 35 launches during the period and included an unverified claim that Starship Flight 14 reached orbit and deployed 26 Starlink V3 satellites.

Broader commentary circulated alongside the estimates, projecting SpaceX AI revenue could reach $275 billion by decade-end and attributing to Elon Musk an expectation that SpaceX’s AI model could surpass leading systems within six months. These projections and attributions lack verification from primary documents.

Trading Activity and Short-Volume

Reported short-volume ratios for SpaceX shares were 53.34 on Sept. 25, 57.74 on Sept. 28, and 59.50 on Sept. 29, 2026, with the last figure described as a two-week high. The short-volume ratio measures trading volume and does not equal short interest or securities-lending balances. Still, a rise in short-volume may indicate increased tactical positioning that could amplify near-term trading swings.

Primary-Source Gap and Implications

No contemporaneous UBS research note, SpaceX earnings release, SEC filing, or transcript dated Sept. 29–30, 2026 substantiated the reported estimates. SpaceX’s investor-relations page lists only a Sept. 24, 2026 statement of changes in beneficial ownership.

This contrast between detailed secondary estimates and the lack of corroborating primary disclosures highlights key verification risks for investors. The divergence reframes near-term decisions about funding needs, execution risk, and the durability of any AI-driven upside. Secondary reports also cited other analyst views, noting TD Cowen initiated coverage with a Buy rating and $200 target, while Clear Street maintained a Buy rating with a $217 target. These ratings were not verified through original research notes.

Until original UBS research or company disclosures are publicly available, traders and investors must weigh the reported assumptions—about revenue mix, heavy capital spending, and launch activity—against elevated trading flows and the practicalities of funding execution.